Literature DB >> 23568080

Serum glutamate dehydrogenase--biomarker for liver cell death or mitochondrial dysfunction?

Hartmut Jaeschke, Mitchell R McGill.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23568080     DOI： 10.1093/toxsci/kft087

Source DB:  PubMed          Journal:  Toxicol Sci        ISSN： 1096-0929            Impact factor:   4.849


× No keyword cloud information.
  7 in total

1.  Serum mitochondrial biomarkers and damage-associated molecular patterns are higher in acetaminophen overdose patients with poor outcome.

Authors:  Mitchell R McGill; Vincent S Staggs; Matthew R Sharpe; William M Lee; Hartmut Jaeschke
Journal:  Hepatology       Date:  2014-08-25       Impact factor: 17.425

2.  Circulating acylcarnitines as biomarkers of mitochondrial dysfunction after acetaminophen overdose in mice and humans.

Authors:  Mitchell R McGill; Feng Li; Matthew R Sharpe; C David Williams; Steven C Curry; Xiaochao Ma; Hartmut Jaeschke
Journal:  Arch Toxicol       Date:  2013-08-25       Impact factor: 5.153

Review 3.  Biomarkers of mitotoxicity after acute liver injury: Further insights into the interpretation of glutamate dehydrogenase.

Authors:  Mitchell R McGill; Hartmut Jaeschke
Journal:  J Clin Transl Res       Date:  2021-01-27

4.  Hepatocyte-like cells generated by direct reprogramming from murine somatic cells can repopulate decellularized livers.

Authors:  Chen Chen; Iris Pla-Palacín; Pedro M Baptista; Peng Shang; Loes A Oosterhoff; Monique E van Wolferen; Louis C Penning; Niels Geijsen; Bart Spee
Journal:  Biotechnol Bioeng       Date:  2018-09-17       Impact factor: 4.530

5.  Glutamate dehydrogenase as a biomarker for mitotoxicity; insights from furosemide hepatotoxicity in the mouse.

Authors:  Rachel J Church; Shelli J Schomaker; J Scott Eaddy; Germaine G Boucher; John M Kreeger; Jiri Aubrecht; Paul B Watkins
Journal:  PLoS One       Date:  2020-10-09       Impact factor: 3.240

6.  Benign elevations in serum aminotransferases and biomarkers of hepatotoxicity in healthy volunteers treated with cholestyramine.

Authors:  Rohit Singhal; Alison H Harrill; Francoise Menguy-Vacheron; Zaid Jayyosi; Hadj Benzerdjeb; Paul B Watkins
Journal:  BMC Pharmacol Toxicol       Date:  2014-08-03       Impact factor: 2.483

7.  Thrombospondin-I is a critical modulator in non-alcoholic steatohepatitis (NASH).

Authors:  Jessica Min-DeBartolo; Franklin Schlerman; Sandeep Akare; Ju Wang; James McMahon; Yutian Zhan; Jameel Syed; Wen He; Baohong Zhang; Robert V Martinez
Journal:  PLoS One       Date:  2019-12-31       Impact factor: 3.240
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.